Oxford BioMedica makes appointment
This article was originally published in Scrip
Executive Summary
The gene therapy company Oxford BioMedica(UK) has announced that John Dawson will join its board on August 1st as a non-executive director and member of the remuneration and audit committees. From 1996 to 2007, Mr Dawson held senior management positions in the European operations of Cephalon, including from 2005 as chief financial officer and head of business development Europe.